HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P C Phillips Selected Research

RNA-Directed DNA Polymerase (Reverse Transcriptase)

1/2002Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.
11/2001Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P C Phillips Research Topics

Disease

15Primitive Neuroectodermal Tumors (PNET)
01/2002 - 03/2000
14Neoplasms (Cancer)
12/2019 - 01/2000
7Medulloblastoma
01/2002 - 03/2000
7Brain Neoplasms (Brain Tumor)
02/2001 - 01/2000
3Glioma (Gliomas)
02/2001 - 09/2000
2Necrosis
12/2019 - 01/2002
2Neuroblastoma
06/2000 - 05/2000
1Stroke (Strokes)
04/2007
1Central Nervous System Neoplasms
04/2007
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2003
1Plexiform Neurofibroma
01/2003

Drug/Important Bio-Agent (IBA)

7Messenger RNA (mRNA)IBA
01/2002 - 03/2000
6Biological ProductsIBA
08/2001 - 03/2000
4Phosphotransferases (Kinase)IBA
07/2001 - 03/2000
3Proteins (Proteins, Gene)FDA Link
01/2002 - 09/2000
3Formaldehyde (Formol)FDA Link
04/2001 - 03/2000
2TNF-Related Apoptosis-Inducing LigandIBA
01/2002 - 09/2000
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2002 - 11/2001
2Caspase 3 (Caspase-3)IBA
01/2002 - 09/2000
2Caspase 8 (Caspase-8)IBA
01/2002 - 09/2000
2ParaffinIBA
04/2001 - 01/2001
2CamptothecinIBA
02/2001 - 01/2001
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
07/2000 - 03/2000
1Methotrexate (Mexate)FDA LinkGeneric
12/2019
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
07/2007
1Thalidomide (Thalomid)FDA Link
01/2003
1Death Domain ReceptorsIBA
01/2002
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2002
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2001
1Vascular Endothelial Growth FactorsIBA
11/2001
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2001
1Transforming Growth Factor alpha (TGF-alpha)IBA
11/2001
1Endothelial Growth FactorsIBA
11/2001
1platelet-derived growth factor AIBA
11/2001
1Vascular Endothelial Growth Factor CIBA
11/2001
1Vascular Endothelial Growth Factor BIBA
11/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2001
1p38 Mitogen-Activated Protein KinasesIBA
07/2001
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2001
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2001
1JNK Mitogen-Activated Protein KinasesIBA
07/2001
1temsirolimusFDA Link
02/2001
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2001
1Sirolimus (Rapamycin)FDA Link
02/2001
1Cisplatin (Platino)FDA LinkGeneric
02/2001
1CyclinsIBA
01/2001
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2001
1Cyclin AIBA
01/2001
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2001
1Cyclin B1IBA
01/2001
1Topoisomerase I InhibitorsIBA
01/2001
1DecitabineFDA Link
09/2000
1MethyltransferasesIBA
09/2000
1Nerve Growth Factors (Neurotrophins)IBA
07/2000
1RNA (Ribonucleic Acid)IBA
06/2000
1NitrogenIBA
06/2000
1SolutionsIBA
06/2000
1Adrenergic Agents (Adrenergic Drugs)IBA
05/2000
1Tetracycline (Achromycin)FDA LinkGeneric
05/2000
1Complementary DNA (cDNA)IBA
05/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2000
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2000
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2000

Therapy/Procedure

4Therapeutics
12/2019 - 01/2000
2Radiotherapy
12/2019 - 04/2000
2Aftercare (After-Treatment)
12/2019 - 01/2001
2Drug Therapy (Chemotherapy)
01/2001 - 05/2000
1Proton Therapy
12/2019
1Combination Drug Therapy (Combination Chemotherapy)
02/2001
1Cranial Irradiation
04/2000